Mayne Pharma Group Limited (MAYNF)

Mayne Pharma Group Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 2, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	265	255	244	304	423	446
Market Cap Growth	43.47%	4.51%	-19.64%	-28.21%	-5.13%	-21.15%
Enterprise Value	209	176	182	494	593	650
Last Close Price	3.16	3.00	2.57	3.12	4.96	5.00
PE Ratio	-	-	3.13	-	-	-
PS Ratio	1.03	0.99	2.00	2.81	1.41	1.42
PB Ratio	0.96	0.84	0.58	0.82	0.73	0.62
P/TBV Ratio	-	-	19.18	3.46	-	5.58
P/FCF Ratio	-	-	-	-	13.52	6.24
P/OCF Ratio	1093.88	-	-	-	9.59	5.74
EV/Sales Ratio	0.78	0.68	1.49	4.56	1.97	2.06
EV/EBITDA Ratio	6.22	14.07	-	-	15.81	14.99
EV/FCF Ratio	-30.07	-	-	-	18.94	9.09
Debt / Equity Ratio	0.09	0.09	0.08	0.77	0.45	0.39
Debt / EBITDA Ratio	0.77	1.72	-	-	6.53	5.97
Debt / FCF Ratio	-	-	-	-	8.33	3.88
Asset Turnover	0.36	0.33	0.14	0.11	0.24	0.26
Inventory Turnover	2.22	2.16	1.05	0.81	2.23	2.53
Quick Ratio	1.10	1.14	1.38	0.61	1.31	1.69
Current Ratio	1.40	1.47	1.78	0.81	1.87	2.24
Return on Equity (ROE)	-23.75%	-30.98%	-54.14%	-33.61%	-23.05%	-9.20%
Return on Assets (ROA)	-0.61%	-2.33%	-9.04%	-5.57%	-0.47%	-0.47%
Return on Capital (ROIC)	-1.29%	-4.74%	-14.04%	-7.39%	-0.60%	-0.58%
Earnings Yield	-30.21%	-45.53%	31.94%	-63.75%	-36.91%	-14.35%
FCF Yield	-2.63%	-6.08%	-13.91%	-3.90%	7.40%	16.03%
Payout Ratio	-	-	38.63%	-	-	-
Buyback Yield / Dilution	3.28%	3.11%	0.15%	-4.74%	-2.75%	-3.68%

Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.